An international team from the Hebrew University of Jerusalem and the Instituto de Microelectronica de Barcelona developed metal iron-based biodegradable magnetoplasmonic nanocapsules (MAPSULES) to eradicate tumours via remote-controlled local delivery of chemotherapy at ultra-low drug concentrations.
The findings of this study were published in ACS Nano Journal and featured on the cover of the latest issue, demonstrated positive therapeutic effects of MAPSULES in biological models carrying human breast tumours. The MAPSULES also boost drug therapeutic action and minimise damage to surrounding tissues.
Read more on the American Friends of Hebrew University website by clicking here.